§ BIOTECHNOLOGY
USD · BiotechnologyCHRS
COHERUS ONCOLOGY INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
72 increased/new, 43 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Timothy G. Youngquist 2020 Irrevocable Trust | 12.3M | n/a | +108% |
| BlackRock | 10.4M | 0.0% | −2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.5M | n/a | n/a |
| SAMSARA BIOCAPITAL, LLC | 3.4M | 0.6% | n/a |
| Geode Capital Management | 3.1M | 0.0% | +14% |
| Kohlberg Kravis Roberts & Co. L.P. | 3.0M | 0.1% | ±0% |
◇ AC INTELLIGENCE
Top institutional owners for CHRS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER56.7% · 0 holders
OTHER26.5% · 105 holders
PASSIVE / INDEX10.2% · 9 holders
DEALER / BANK4.0% · 18 holders
TACTICAL / MACRO1.6% · 3 holders
SYSTEMATIC / QUANT0.6% · 5 holders
QUALITY / COMPOUNDER0.4% · 10 holders
INCOME / DEFENSIVE0.1% · 6 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for CHRS in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention CHRS yet.